Company / Operating Income per Share
Adaptimmune Therapeutics PLC Operating Income per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.05
FY2024
5-year range
-$0.21 / -$0.05
FY2020-FY2024
Trend
+64.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 9 years, ranging from $-0.22 in FY2019 to $-0.05 in FY2024.
Based on SEC 10-K filings.
-0.05 in FY2024.
Improved from $-0.18 to $-0.05 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share increased 64.4% year-over-year.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.05 | +64.4% |
| FY2023 | -$0.14 | +19.8% |
| FY2022 | -$0.18 | -1.1% |
| FY2021 | -$0.17 | +17.4% |
| FY2020 | -$0.21 | +5.1% |
| FY2019 | -$0.22 | -52.0% |
| FY2018 | -$0.15 | +22.8% |
| FY2017 | -$0.19 | -10.8% |
| FY2016 | -$0.17 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026